Susan Lalondrelle

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications

Modelling the time to cervical cancer elimination in England: strategies for achieving elimination by 2040.

Modelling the time to cervical cancer elimination in England: strategies for achieving elimination by 2040.

Journal: BMJ public health
Published: October 31, 2025

Outcomes of pelvic and para-aortic stereotactic reirradiation for gynaecological cancer recurrence.

Outcomes of pelvic and para-aortic stereotactic reirradiation for gynaecological cancer recurrence.

Journal: Clinical and translational radiation oncology
Published: May 30, 2025

Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer.

Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer.

Journal: Gynecologic oncology
Published: March 10, 2025

Survival disparities in women with endometrial cancer based on metastasis size in the sentinel lymph node: A tertiary cancer centre observational cohort study.

Survival disparities in women with endometrial cancer based on metastasis size in the sentinel lymph node: A tertiary cancer centre observational cohort study.

Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: January 31, 2025

Real World Multi-centre UK Review of Nivolumab Monotherapy in Metastatic Endometrial Cancer With Mismatch Repair Deficiency During COVID-19.

Real World Multi-centre UK Review of Nivolumab Monotherapy in Metastatic Endometrial Cancer With Mismatch Repair Deficiency During COVID-19.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: December 10, 2024

Quantitative and automatic plan-of-the-day assessment to facilitate adaptive radiotherapy in cervical cancer.

Quantitative and automatic plan-of-the-day assessment to facilitate adaptive radiotherapy in cervical cancer.

Journal: Physics in medicine and biology
Published: December 09, 2024

Domain-Adaptive and Per-Fraction Guided Deep Learning Framework for Magnetic Resonance Imaging-Based Segmentation of Organs at Risk in Gynecologic Cancers.

Domain-Adaptive and Per-Fraction Guided Deep Learning Framework for Magnetic Resonance Imaging-Based Segmentation of Organs at Risk in Gynecologic Cancers.

Journal: Advances in radiation oncology
Published: July 01, 2024

Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy.

Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy.

Journal: JAMA network open
Published: May 01, 2024

Implementing Plan of the Day for Cervical Cancer: A Comparison of Target Volume Generation Methods.

Implementing Plan of the Day for Cervical Cancer: A Comparison of Target Volume Generation Methods.

Journal: Advances in radiation oncology
Published: January 04, 2024

Predicting cervical cancer target motion using a multivariate regression model to enable patient selection for adaptive external beam radiotherapy.

Predicting cervical cancer target motion using a multivariate regression model to enable patient selection for adaptive external beam radiotherapy.

Journal: Physics and imaging in radiation oncology
Published: October 17, 2023

Bladder Tumor-Focused Adaptive Radiation Therapy: Clinical Outcomes of a Phase I Dose Escalation Study.

Bladder Tumor-Focused Adaptive Radiation Therapy: Clinical Outcomes of a Phase I Dose Escalation Study.

Journal: International journal of radiation oncology, biology, physics
Published: October 10, 2023

T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignancies.

T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignancies.

Journal: Frontiers in oncology
Published: September 19, 2023
Showing 1-12 of 49

Last Updated: 09/26/2026